Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Veracyte Inc (VCYT)

Veracyte Inc (VCYT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,955,269
  • Shares Outstanding, K 71,753
  • Annual Sales, $ 219,510 K
  • Annual Income, $ -75,560 K
  • 60-Month Beta 1.39
  • Price/Sales 8.88
  • Price/Cash Flow N/A
  • Price/Book 1.86
Trade VCYT with:

Options Overview Details

View History
  • Implied Volatility 80.98% ( -4.73%)
  • Historical Volatility 100.07%
  • IV Percentile 60%
  • IV Rank 55.45%
  • IV High 139.77% on 06/10/22
  • IV Low 7.80% on 10/19/22
  • Put/Call Vol Ratio 1.67
  • Today's Volume 16
  • Volume Avg (30-Day) 87
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 3,966
  • Open Int (30-Day) 4,146

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.15
  • Number of Estimates 4
  • High Estimate -0.11
  • Low Estimate -0.20
  • Prior Year -0.15
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.05 +16.44%
on 11/09/22
31.09 -13.67%
on 11/11/22
+2.11 (+8.53%)
since 11/07/22
3-Month
14.92 +79.89%
on 10/21/22
31.09 -13.67%
on 11/11/22
+7.28 (+37.22%)
since 09/07/22
52-Week
14.85 +80.74%
on 05/12/22
45.58 -41.11%
on 12/17/21
-14.36 (-34.85%)
since 12/07/21

Most Recent Stories

More News
Veracyte (VCYT) Reports Q3 Loss, Tops Revenue Estimates

Veracyte (VCYT) delivered earnings and revenue surprises of 50% and 12.82%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

VCYT : 26.84 (-1.50%)
RWLK : 0.8950 (-1.65%)
Veracyte: Q3 Earnings Snapshot

Veracyte: Q3 Earnings Snapshot

VCYT : 26.84 (-1.50%)
Veracyte Announces Third Quarter 2022 Financial Results

Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the third quarter ended September 30, 2022.

VCYT : 26.84 (-1.50%)
Veracyte Announces Three Abstracts to Be Presented at SITC 2022 Annual Meeting

Veracyte, Inc. (Nasdaq: VCYT) announced today that three abstracts highlighting the company’s unique, multi-omics immuno-oncology capabilities and offerings will be presented at the Society for Immunotherapy...

VCYT : 26.84 (-1.50%)
Veracyte to Participate in the Credit Suisse 31st Annual Healthcare Conference

Veracyte, Inc . (Nasdaq: VCYT) announced today that Marc Stapley, chief executive officer, and Rebecca Chambers, chief financial officer, will participate in a fireside chat at the Credit Suisse 31 st...

VCYT : 26.84 (-1.50%)
New Data Suggest Decipher GRID-Derived Genomic Signature Can Help Identify Men with Prostate Cancer Who Should Receive High-Dose Radiotherapy

Veracyte, Inc . (Nasdaq: VCYT) announced new data demonstrating that a genomic signature derived from the company’s Decipher GRID database could help determine which men experiencing prostate cancer...

VCYT : 26.84 (-1.50%)
Veracyte Data Presented at ATA Annual Meeting Provide New Insights into Molecular Underpinnings of Thyroid Cancer

Veracyte, Inc. (Nasdaq: VCYT) today announced data that provide new insights into thyroid tumor behavior. The findings were derived from whole-transcriptome analyses of Veracyte’s extensive thyroid...

VCYT : 26.84 (-1.50%)
New Data Presented at CHEST 2022 Reinforce Clinical Value of Veracyte’s Genomic Tests in Interstitial Lung Disease and Lung Cancer

Veracyte, Inc . (Nasdaq: VCYT) today announced that two abstracts highlighting the clinical value of the company’s Envisia Genomic Classifier and Percepta Nasal Swab tests in interstitial lung disease...

VCYT : 26.84 (-1.50%)
Veracyte to Release Third Quarter 2022 Financial Results on November 2, 2022

Veracyte, Inc. (Nasdaq: VCYT) announced today that it will release financial results for the third quarter of 2022 after the close of market on Wednesday, November 2, 2022. Company management will host...

VCYT : 26.84 (-1.50%)
Should Growth Investors Buy This Little-Known Stock?

Due to the downturn in the broader market, this genetic-testing stock has crashed so far this year.

COMP : 2.64 (-4.35%)
VCYT : 26.84 (-1.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also...

See More

Key Turning Points

3rd Resistance Point 28.84
2nd Resistance Point 28.41
1st Resistance Point 27.63
Last Price 26.84
1st Support Level 26.42
2nd Support Level 25.99
3rd Support Level 25.21

See More

52-Week High 45.58
Fibonacci 61.8% 33.84
Fibonacci 50% 30.22
Last Price 26.84
Fibonacci 38.2% 26.59
52-Week Low 14.85

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar